NEW YORK, May 3 - Private biotech firm Placer has chosen Illumina to provide SNP-genotyping services.
The deal, announced yesterday evening, calls for Illumina to use its BeadArray technology to genotype SNPs thought to be linked with psoriasis and other skin conditions. The firm will also design assays for the SNP loci.
The deal comes one week after Illumina penned a similar deal with the Laboratory of Psychiatric Genomics at the University of California, San Diego.
Click here for more information about the Placer agreement.